Literature DB >> 10517529

Characterization of a crosslinked high amylose starch excipient.

P Le Bail1, F G Morin, R H Marchessault.   

Abstract

A controlled release excipient based on sodium trimetaphosphate (STMP) crosslinked high amylose starch has been examined by 13C CP/MAS NMR. The dry excipient powder is pressed to a hard tablet whose volume increase in H2O runs parallel to the STMP concentration used. The known polymorph resonances of single helix 'V' starch (hydrated) and double helix 'B' starch (hydrated) both contribute to the spectrum corresponding to the swollen tablet. The wet tablet when loaded with a pharmaceutical agent provides a near zero-order release profile for up to 20 h. The swelling and drug release behaviour is explained in terms of self-assembly of the STMP treated starch nanomolecular particles. These particles are drawn together by "self-assembly" due to formation of amylose double helices as water penetrates the tablet. An optimum level of chemical crosslinking ensures the integrity of the swollen tablet whose sponge-like structure enclosed by a membranous surface is responsible for sustained release.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517529     DOI: 10.1016/s0141-8130(99)00082-3

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  3 in total

1.  Easy preparation of dietary fiber with the high water-holding capacity from food sources.

Authors:  Eiji Yamazaki; Kazumi Murakami; Osamu Kurita
Journal:  Plant Foods Hum Nutr       Date:  2005-03       Impact factor: 3.921

2.  Modification of flow and compressibility of corn starch using quasi-emulsion solvent diffusion method.

Authors:  Abbas Akhgari; Hasti Sadeghi; Mohammad Ali Dabbagh
Journal:  Iran J Basic Med Sci       Date:  2014-08       Impact factor: 2.699

3.  Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation.

Authors:  Jing-Yi Hou; Li-Na Gao; Fan-Yun Meng; Yuan-Lu Cui
Journal:  Mar Drugs       Date:  2014-12-01       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.